Finch Therapeutics Group, Inc. (FNCH)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Finch Therapeutics Group, Inc. chart...

About the Company

Jeffery Alan "Jeff" Smisek (born August 17, 1954) is an American businessman and investor who currently serves as the president of GOOSE Capital and on the board of directors of Finch Therapeutics. Smisek previously worked in the airline industry as the chairman, president, and chief executive officer (CEO) of Continental Airlines and, later, of United Airlines.

Exchange

Nasdaq

$114M

Total Revenue

123

Employees

$4M

Market Capitalization

-0.11

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $FNCH News

Finch Therapeutics Group Inc

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Finch Therapeutics Group (NASDAQ: FNCH)

6d ago, source: The Motley Fool

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the ...

Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare movers

on MSN ago, source:

Capricor Therapeutics (CAPR) +14%. Cyclacel Pharmaceuticals (CYCC) +14%. IMAC Holdings (BACK) +11%. Prenetics Global (PRE) ...

Finch Therapeutics Group, Inc.

3mon ago, source: CNN

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the ...

Finch Therapeutics Group Inc.

2y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Finch Therapeutics Group Inc (FNCH)

1mon ago, source: Investing

Pre-Open Stock Movers: Finch Therapeutics Group (NASDAQ:FNCH) 70% HIGHER; announced that the FDA has removed the clinical hold on Finch's investigational new drug (IND) ...

Finch Therapeutics Group, Inc. (FNCH)

1y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Finch Therapeutics Group Inc.

1y ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...